BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Vertex Pharmaceuticals Incorporated (“Vertex” or the “Company”) (Nasdaq: VRTX) concerning the Company’s and its officers’ possible violations of federal securities laws.
On October 30, 2015, the Company disclosed that in the third quarter of 2015, it received a subpoena from the United States Department of Justice related to Vertex’s marketed medicines. The Company further disclosed that the subpoena requests documents related to the Company’s “Good Laboratory Practices in a bioanalytical laboratory.” Vertex also stated that it was in the process of responding to the subpoena and that it intend to cooperate.
On this news, Vertex shares fell during after-hours trading on October 30, 2015, thereby injuring investors.
If you purchased Vertex securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.